S

Stan Cassidy Centre for Rehabilitation | Research Department

Research site
(Unclaimed)
Location
800 Priestman Street, Fredericton, New Brunswick, Canada

Site insights

Top conditions

Top treatments

Levosimendan
CLS-7262
PGN-EDO51
Reldesemtiv
CK-2017357
Fampridine
ODM-109
CY 5031
tirasemtiv

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 10 total trials

A Phase 1 Study to Investigate the Safety and Pharmacokinetics of ABBV-CLS-7262 in Patients With Amyotrophic Lateral Sclerosis

ABBV-CLS-7262 is an investigational drug being researched for the treatment of Amyotrophic Lateral Sclerosis. This is an up to 156-week, 2-part study...

Active, not recruiting
ALS
Amyotrophic Lateral Sclerosis
Drug: Placebo
Drug: ABBV-CLS-7262

The primary purpose of the MAD period is to evaluate the safety and tolerability of multiple ascending intravenous (IV) doses of PGN-EDO51 administer...

Enrolling
Duchenne Muscular Dystrophy
Drug: PGN-EDO51

Trial sponsors

C
O
Acorda Therapeutics logo
Calico Life Sciences logo
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems